Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Jun 2022
Historique:
pubmed: 11 6 2021
medline: 7 6 2022
entrez: 10 6 2021
Statut: ppublish

Résumé

Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein (LDL) cholesterol levels, xanthomas including Achilles tendon thickening, and premature coronary artery disease (CAD). Carotid intima-media thickness (IMT) is a well-established surrogate marker for CAD in FH and Achilles tendon thickening is a specific physical finding in patients with FH. The objective of the present study was to identify factors associated with carotid IMT and Achilles tendon thickness in FH heterozygotes on lipid-lowering therapy. This study also aimed to examine the follow-up changes in carotid IMT and Achilles tendon thickness among them in the current real-world FH practice. The current study is a subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study. The severity of carotid atherosclerosis was assessed with the maximal and mean IMT using ultrasonography, and Achilles tendon thickness was measured using X-rays. The present study used 571 patients under medical treatment for heterozygous FH who had baseline measurements for maximal IMT (n=511), mean IMT (n=459), or Achilles tendon thickness (n=486). The IMT was measured annually, and Achilles tendon thickness was evaluated every two years. Higher LDL cholesterol (LDL-C) level and lower HDL cholesterol (HDL-C) level were associated with greater maximal and mean IMT as well as greater Achilles tendon thickness. Achilles tendon thickness tended to be greater in patients who had a smoking history than in never-smokers. Maximal IMT and Achilles tendon thickness were significantly greater in patients with CAD than in those without. Additionally, lower HDL-C level and hypertension were associated with higher values of maximal and mean IMT, suggesting the importance of comprehensive risk management including reduced HDL-C and blood pressure control in FH care. In longitudinal observations, percentage changes in maximal IMT and mean IMT gradually increased during the observation period. In contrast, percentage changes in Achilles tendon thickness became progressively thinner throughout the observation period. We found a positive association between LDL-C levels and severity of carotid atherosclerosis in heterozygous FH patients on treatment. This observation suggests the insufficiency of lipid-lowering therapy and the presence of therapeutic inertia among clinicians in the real-world FH practice.

Identifiants

pubmed: 34108342
doi: 10.5551/jat.62925
pmc: PMC9174085
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

906-922

Références

Arterioscler Thromb Vasc Biol. 2006 May;26(5):1107-13
pubmed: 16556855
BMJ. 2014 Jul 18;349:g4379
pubmed: 25038074
Clin Investig. 1992 Mar-Apr;70(3-4):263-8
pubmed: 1521040
Arch Intern Med. 2003 Aug 11-25;163(15):1837-41
pubmed: 12912721
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):181-8
pubmed: 26543100
Atherosclerosis. 2011 Feb;214(2):404-7
pubmed: 21146822
Can J Cardiol. 2017 Mar;33(3):385-392
pubmed: 27931859
Int Heart J. 2017 Feb 7;58(1):88-94
pubmed: 28123161
J Atheroscler Thromb. 2021 Feb 1;28(2):103-123
pubmed: 32336695
Stroke. 2018 Jan;49(1):107-113
pubmed: 29191850
Atherosclerosis. 2018 Oct;277:362-368
pubmed: 30270072
Stroke. 2004 Dec;35(12):2788-94
pubmed: 15528460
Nat Rev Dis Primers. 2017 Dec 07;3:17093
pubmed: 29219151
J Cardiol. 2018 Jan;71(1):1-7
pubmed: 28784313
Atherosclerosis. 2009 Jul;205(1):151-5
pubmed: 19070856
Eur Heart J. 2010 Apr;31(8):1007-12
pubmed: 20019024
Circ J. 2014;78(12):2955-62
pubmed: 25319317
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
J Atheroscler Thromb. 2018 Aug 1;25(8):751-770
pubmed: 29877295
Lancet. 2004 Jan 31;363(9406):369-70
pubmed: 15070569
J Atheroscler Thromb. 2014;21(8):799-815
pubmed: 24717757
Am J Cardiol. 1986 Jun 27;57(16):29H-35H
pubmed: 3728307
Circulation. 2007 Aug 7;116(6):664-8
pubmed: 17664376
Am J Cardiol. 2005 Jan 15;95(2):264-6
pubmed: 15642565
BMJ. 1991 Oct 12;303(6807):893-6
pubmed: 1933004
J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85
pubmed: 26988947
Atherosclerosis. 2012 Apr;221(2):438-44
pubmed: 22321873
Am J Pathol. 1992 Jul;141(1):99-106
pubmed: 1378698
J Atheroscler Thromb. 2012;19(4):369-75
pubmed: 22333410
Eur J Clin Invest. 2005 Apr;35(4):236-44
pubmed: 15816992
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
J Atheroscler Thromb. 2008 Dec;15(6):292-303
pubmed: 19060422
Atherosclerosis. 1977 Sep;28(1):61-8
pubmed: 911369
Atherosclerosis. 2009 Dec;207(2):311-7
pubmed: 19439299
FEBS Lett. 2005 Aug 15;579(20):4503-12
pubmed: 16083882
Circ J. 2017 Nov 24;81(12):1879-1885
pubmed: 28652530
Stroke. 1997 Oct;28(10):1919-25
pubmed: 9341696
Arterioscler Thromb. 1992 Jan;12(1):70-7
pubmed: 1731860
Atherosclerosis. 2010 Mar;209(1):189-94
pubmed: 19818960
Circulation. 2004 Jun 15;109(23 Suppl 1):III33-8
pubmed: 15198964
Eur Heart J. 2017 May 21;38(20):1573-1579
pubmed: 28159968
Circ J. 2012;76(1):221-9
pubmed: 22094911
J Atheroscler Thromb. 2022 May 1;29(5):608-638
pubmed: 33980760

Auteurs

Masatsune Ogura (M)

Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.

Mariko Harada-Shiba (M)

Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.

Daisaku Masuda (D)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Present address: Department of Cardiology, Rinku General Medical Center.

Hidenori Arai (H)

The National Center for Geriatrics and Gerontology.

Hideaki Bujo (H)

Department of Clinical Laboratory and Experimental Research Medicine, Toho University, Sakura Medical Center.

Shun Ishibashi (S)

Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Nobuhiko Koga (N)

Shin Koga Hospital, Kurume City.

Shinichi Oikawa (S)

Diabetes and Lifestyle Disease Center, Fukujyuji Hospital, Japan Anti-Tuberculosis Association (JATA).

Shizuya Yamashita (S)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Department of Community Medicine, Osaka University Graduate School of Medicine.
Present address: Department of Cardiology, Rinku General Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH